These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7060908)

  • 1. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat.
    Koo J; Ho J; Lam SK; Wong J; Ong GB
    Gastroenterology; 1982 May; 82(5 Pt 1):864-70. PubMed ID: 7060908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.
    Hamilton I; Worsley BW; O'Connor HJ; Axon AT
    Gut; 1983 Dec; 24(12):1148-51. PubMed ID: 6357964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate.
    Stables R; Campbell CJ; Clayton NM; Clitherow JW; Grinham CJ; McColm AA; McLaren A; Trevethick MA
    Aliment Pharmacol Ther; 1993 Jun; 7(3):237-46. PubMed ID: 8364129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled clinical trial with De-Nol (tripotassium dicitrato bismuthate) in patients with gastric ulcer.
    Patty I; Deák G; Jávor T; Mózsik G; Nagy L; Tárnok F
    Int J Tissue React; 1983; 5(4):397-401. PubMed ID: 6368445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse.
    Sutton DR
    Gut; 1982 Jul; 23(7):621-4. PubMed ID: 7044913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucus secretion in gastric ulcer patients treated with tripotassium dicitrato bismuthate (De-Nol).
    Hollanders D; Morrissey SM; Mehta J
    Br J Clin Pract; 1983 Mar; 37(3):112-4. PubMed ID: 6882629
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine.
    Lam SK; Lee NW; Koo J; Hui WM; Fok KH; Ng M
    Gut; 1984 Jul; 25(7):703-6. PubMed ID: 6376292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.
    Hamilton I; O'Connor HJ; Wood NC; Bradbury I; Axon AT
    Gut; 1986 Jan; 27(1):106-10. PubMed ID: 3512382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of tripotassium dicitrato bismuthate with macrophages in the rat and in vitro.
    Soutar RL; Coghill SB
    Gastroenterology; 1986 Jul; 91(1):84-93. PubMed ID: 3710085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers.
    Lane M; Lee S; Tasman-Jones C; Nicholson G
    N Z Med J; 1985 Mar; 98(775):191-2. PubMed ID: 3885084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of tripotassium-dicitrato-bismuthate (TDB) and cimetidine in peptic ulcer disease, a control study of 40 gastric ulcer and 80 duodenal ulcer.
    Chearanai O; Kachintorn U; Plengvanit U
    J Med Assoc Thai; 1987 Apr; 70(4):176-80. PubMed ID: 3612003
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tripotassium-dicitrato bismuthate in the treatment of peptic ulcer and the prevention of its recurrence].
    Gibiński K; Nowak A; Marlicz K; Depczyńska A; Dzieniszewski J; Milewski B; Gabryelewicz A; Kosidło S
    Pol Tyg Lek; 1984 Nov; 39(47):1547-50. PubMed ID: 6393096
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cimetidine and tripotassium-dicitrato bismuthate (Duosol) in chronic duodenal ulcer].
    Bergoz R
    Schweiz Med Wochenschr; 1985 Jul; 115(29):1024-5. PubMed ID: 4048901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of tripotassium dicitrato bismuthate on the rat stomach.
    Waldum HL; Qvigstad G; Mårvik R; Brenna E; Syversen U; Sandvik AK
    Aliment Pharmacol Ther; 1994 Aug; 8(4):425-31. PubMed ID: 7527257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric pharmacological activities of tripotassium dicitrato bismuthate in rats and dogs.
    Soldani G; Del Tacca M; Bernardini C; Polloni A; Martinotti E; Malandrino S; Borsa M; Tonon GC
    Pharmacol Res Commun; 1985 Nov; 17(11):1017-26. PubMed ID: 3937162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tripotassium dicitrato bismuthate in the therapy of peptic ulcer: comparison with ranitidine in short-term treatment].
    Capurso L; Tarquini M; Luzietti L; Palomba M; Bazuro G; Papi C; Fracasso P; Koch M
    Clin Ter; 1984 May; 109(4):335-44. PubMed ID: 6088161
    [No Abstract]   [Full Text] [Related]  

  • 17. The ultrastructural localisation of De-Nol (colloidal tripotassium dicitrato-bismuthate--TDB) in the upper gastrointestinal tract of man and rodents following oral and instrumental administration.
    Coghill SB; Hopwood D; McPherson S; Hislop S
    J Pathol; 1983 Feb; 139(2):105-14. PubMed ID: 6827397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the absorption and excretion of tripotassium dicitrato-bismuthate in man.
    Lee SP
    Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):359-64. PubMed ID: 7335960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of gastric mucosal lesions in rats by tri-potassium di-citrato bismuthate.
    Malandrino S; Campagnoli G; Borsa M; Guidoboni R; Tonon GC
    Arzneimittelforschung; 1984; 34(1):30-1. PubMed ID: 6367754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased healing of gastric and duodenal ulcers in a controlled trial using tripotassium dicitrato-bismuthate.
    Lee SP; Nicholson GI
    Med J Aust; 1977 May; 1(22):808-12. PubMed ID: 329077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.